Implication of purinergic P2X7 receptor in M. tuberculosis infection and host interaction mechanisms: A mouse model study

Immunobiology

Volumn 218, Issue 8, 2013, Pages 1104-1112

  Santos, André A ^a   Rodrigues Junior, Valnês ^a   Zanin, Rafael F ^a   Borges, Thiago J ^a   Bonorino, Cristina ^a   Coutinho Silva, Robson ^b   Takyia, Christina M ^b   Santos, Diógenes S ^a   Campos, Maria M ^a   Morrone, Fernanda B ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ATP; Mouse; Mycobacterium tuberculosis; P2X7 receptor; RAW 264.7

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD4 ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; PURINERGIC P2X7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ CD25+ T LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; LUNG INFILTRATE; MACROPHAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN WEIGHT; SPLENOMEGALY; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; LUNG; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, PURINERGIC P2X7; TUBERCULOSIS;

EID: 84878613116     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.03.003     Document Type: Article

References (68)

1. Angeli V., Ginhoux F., Llodra J., Quemeneur L., Frenette P.S., Skobe M., Jessberger R., Merad M., Randolph G.J. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006, 24:203.
2. Azad A.K., Sadee W., Schlesinger L.S. Innate immune gene polymorphisms in tuberculosis. Infect. Immun. 2012, 80:3343.
3. Barth K., Weinhold K., Guenther A., Young M.T., Schnittler H., Kasper M. Caveolin-1 influences P2X7 receptor expression and localization in mouse lung alveolar epithelial cells. FEBS J. 2007, 274:3021.
4. Basso A.M., Bratcher N.A., Harris R.R., Jarvis M.F., Decker M.W., Rueter L.E. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav. Brain Res. 2009, 198:83.
5. Biswas D., Qureshi O.S., Lee W.Y., Croudace J.E., Mura M., Lammas D.A. ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages. BMC Immunol. 2008, 9:35.
6. Burnstock G. Purinergic signalling-an overview. Novartis Found. Symp. 2006, 276:26.
7. Burnstock G. Introductory overview of purinergic signalling. Front. Biosci. (Elite Ed.) 2011, 3:896.
8. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 2004, 240:31.
9. Chaves S.P., Torres-Santos E.C., Marques C., Figliuolo V.R., Persechini P.M., Coutinho-Silva R., Rossi-Bergmann B. Modulation of P2X(7) purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination. Microbes Infect. 2009, 11:842.
10. Chen Z., Jin N., Narasaraju T., Chen J., McFarland L.R., Scott M., Liu L. Identification of two novel markers for alveolar epithelial type I and II cells. Biochem. Biophys. Res. Commun. 2004, 319:774.
11. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., Egerton J., Murfin M., Richardson J., Peck W.L., Grahames C.B., Casula M.A., Yiangou Y., Birch R., Anand P., Buell G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386.
12. Coutinho-Silva R., Knight G.E., Burnstock G. Impairment of the splenic immune system in P2X(2)/P2X(3) knockout mice. Immunobiology 2005, 209:661.
13. Coutinho-Silva R., Monteiro da Cruz C., Persechini P.M., Ojcius D.M. The role of P2 receptors in controlling infections by intracellular pathogens. Purinergic Signal 2007, 3:83.
14. Coutinho-Silva R., Perfettini J.L., Persechini P.M., Dautry-Varsat A., Ojcius D.M. Modulation of P2Z/P2X(7) receptor activity in macrophages infected with Chlamydia psittaci. Am. J. Physiol. Cell Physiol. 2001, 280:C81.
15. Coutinho-Silva R., Stahl L., Raymond M.N., Jungas T., Verbeke P., Burnstock G., Darville T., Ojcius D.M. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity 2003, 19:403.
16. Cynamon M.H., Zhang Y., Harpster T., Cheng S., DeStefano M.S. High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection. Antimicrob. Agents Chemother. 1999, 43:2922.
17. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol. Sci. 2007, 28:465.
18. Donnelly-Roberts D.L., Jarvis M.F. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol. 2007, 151:571.
19. Enserink M. Driving a stake into resurgent TB. Science 2001, 293:234.
20. Fairbairn I.P., Stober C.B., Kumararatne D.S., Lammas D.A. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J. Immunol. 2001, 167:3300.
21. Fatkenheuer G., Taelman H., Lepage P., Schwenk A., Wenzel R. The return of tuberculosis. Diagn. Microbiol. Infect. Dis. 1999, 34:139.
22. Feng L., Sun X., Csizmadia E., Han L., Bian S., Murakami T., Wang X., Robson S.C., Wu Y. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 2011, 13:206.
23. Fernando S.L., Saunders B.M., Sluyter R., Skarratt K.K., Goldberg H., Marks G.B., Wiley J.S., Britton W.J. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2007, 175:360.
24. Fernando S.L., Saunders B.M., Sluyter R., Skarratt K.K., Wiley J.S., Britton W.J. Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J. Infect. Dis. 2005, 192:149.
25. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Melchiorri L., Baricordi O.R., Di Virgilio F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 1997, 159:1451.
26. Goncalves R.G., Gabrich L., Rosario A., Takiya C.M., Ferreira M.L., Chiarini L.B., Persechini P.M., Coutinho-Silva R., Leite M. The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int. 2006, 70:1599.
27. Gu B.J., Zhang W., Worthington R.A., Sluyter R., Dao-Ung P., Petrou S., Barden J.A., Wiley J.S. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 2001, 276:11135.
28. Honore P., Donnelly-Roberts D., Namovic M.T., Hsieh G., Zhu C.Z., Mikusa J.P., Hernandez G., Zhong C., Gauvin D.M., Chandran P., Harris R., Medrano A.P., Carroll W., Marsh K., Sullivan J.P., Faltynek C.R., Jarvis M.F. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 2006, 319:1376.
29. Klemens S.P., Sharpe C.A., Rogge M.C., Cynamon M.H. Activity of levofloxacin in a murine model of tuberculosis. Antimicrob. Agents Chemother. 1994, 38:1476.
30. Kraal G. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 1992, 132:31.
31. Kusner D.J., Adams J. ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J. Immunol. 2000, 164:379.
32. Kusner D.J., Barton J.A. ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J. Immunol. 2001, 167:3308.
33. Labasi J.M., Petrushova N., Donovan C., McCurdy S., Lira P., Payette M.M., Brissette W., Wicks J.R., Audoly L., Gabel C.A. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 2002, 168:6436.
34. Lammas D.A., Stober C., Harvey C.J., Kendrick N., Panchalingam S., Kumararatne D.S. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 1997, 7:433.
35. Levesque S.A., Kukulski F., Enjyoji K., Robson S.C., Sevigny J. NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur. J. Immunol. 2010, 40:1473.
36. Li X., Zhou L., Feng Y.H., Abdul-Karim F.W., Gorodeski G.I. The P2X7 receptor: a novel biomarker of uterine epithelial cancers. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1906.
37. Lucattelli M., Cicko S., Muller T., Lommatzsch M., De Cunto G., Cardini S., Sundas W., Grimm M., Zeiser R., Durk T., Zissel G., Sorichter S., Ferrari D., Di Virgilio F., Virchow J.C., Lungarella G., Idzko M. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am. J. Respir. Cell Mol. Biol. 2011, 44:423.
38. Malik Z.A., Denning G.M., Kusner D.J. Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J. Exp. Med. 2000, 191:287.
39. Marcellino D., Suarez-Boomgaard D., Sanchez-Reina M.D., Aguirre J.A., Yoshitake T., Yoshitake S., Hagman B., Kehr J., Agnati L.F., Fuxe K., Rivera A. On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079. J. Neural Transm. 2010, 117:681.
40. Marques-da-Silva C., Chaves M.M., Rodrigues J.C., Corte-Real S., Coutinho-Silva R., Persechini P.M. Differential modulation of ATP-induced P2X7-associated permeabilities to cations and anions of macrophages by infection with Leishmania amazonensis. PLoS ONE 2011, 6:e25356.
41. Martins de Sousa E., Bonfim de Bortoli F., Amaral E.P., Batista A.C., Liberman Kipnis T., Marques Cardoso A., Kipnis A., Junqueira-Kipnis A.P. Acute immune response to Mycobacterium massiliense in C57BL/6 and BALB/c mice. Infect. Immun. 2010, 78:1571.
42. Martins J.P., Silva R.B., Coutinho-Silva R., Takiya C.M., Battastini A.M., Morrone F.B., Campos M.M. The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice. Br. J. Pharmacol. 2012, 165:183.
43. Mascarello A., Chiaradia L.D., Vernal J., Villarino A., Guido R.V., Perizzolo P., Poirier V., Wong D., Martins P.G., Nunes R.J., Yunes R.A., Andricopulo A.D., Av-Gay Y., Terenzi H. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth. Bioorg. Med. Chem. 2010, 18:3783.
44. Mebius R.E., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005, 5:606.
45. Molloy A., Laochumroonvorapong P., Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J. Exp. Med. 1994, 180:1499.
46. Moncao-Ribeiro L.C., Cagido V.R., Lima-Murad G., Santana P.T., Riva D.R., Borojevic R., Zin W.A., Cavalcante M.C., Rica I., Brando-Lima A.C., Takiya C.M., Faffe D.S., Coutinho-Silva R. Lipopolysaccharide-induced lung injury: role of P2X7 receptor. Respir. Physiol. Neurobiol. 2011, 179:314.
47. Muller T., Vieira R.P., Grimm M., Durk T., Cicko S., Zeiser R., Jakob T., Martin S.F., Blumenthal B., Sorichter S., Ferrari D., Di Virgillio F., Idzko M. A potential role for P2X7R in allergic airway inflammation in mice and humans. Am. J. Respir. Cell Mol. Biol. 2011, 44:456.
48. Myers A.J., Eilertson B., Fulton S.A., Flynn J.L., Canaday D.H. The purinergic P2X7 receptor is not required for control of pulmonary Mycobacterium tuberculosis infection. Infect. Immun. 2005, 73:3192.
49. Nino-Moreno P., Portales-Perez D., Hernandez-Castro B., Portales-Cervantes L., Flores-Meraz V., Baranda L., Gomez-Gomez A., Acuna-Alonzo V., Granados J., Gonzalez-Amaro R. P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis. Clin. Exp. Immunol. 2007, 148:469.
50. Palomino J.C., Martin A., Camacho M., Guerra H., Swings J., Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2002, 46:2720.
51. Pethe K., Swenson D.L., Alonso S., Anderson J., Wang C., Russell D.G. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13642.
52. Rassendren F., Buell G.N., Virginio C., Collo G., North R.A., Surprenant A. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J. Biol. Chem. 1997, 272:5482.
53. Rodrigues-Junior V.S., Dos Santos Junior A., Dos Santos A.J., Schneider C.Z., Calixto J.B., Sousa E.H., de Franca Lopes L.G., Souto A.A., Basso L.A., Santos D.S., Campos M.M. Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection. Int. J. Antimicrob. Agents 2012, 40:182.
54. Saini D., Hopkins G.W., Seay S.A., Chen C.J., Perley C.C., Click E.M., Frothingham R. Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice. Tuberculosis (Edinburgh) 2012, 92:160.
55. Saunders B.M., Fernando S.L., Sluyter R., Britton W.J., Wiley J.S. A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J. Immunol. 2003, 171:5442.
56. Schenk U., Frascoli M., Proietti M., Geffers R., Traggiai E., Buer J., Ricordi C., Westendorf A.M., Grassi F. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal. 2011, 4:ra12.
57. Singla N., Gupta D., Joshi A., Batra N., Singh J. Genetic polymorphisms in the P2X7 gene and its association with susceptibility to tuberculosis. Int. J. Tuberc. Lung Dis. 2012, 16:224.
58. Sluyter R., Dalitz J.G., Wiley J.S. P2X7 receptor polymorphism impairs extracellular adenosine 5'-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun. 2004, 5:588.
59. Sluyter R., Shemon A.N., Wiley J.S. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J. Immunol. 2004, 172:3399.
60. Sluyter R., Stokes L. Significance of P2X7 receptor variants to human health and disease. Recent Pat. DNA Gene Seq. 2011, 5:41.
61. Sluyter R., Wiley J.S. Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors. Int. Immunol. 2002, 14:1415.
62. Smith R.A., Alvarez A.J., Estes D.M. The P2X7 purinergic receptor on bovine macrophages mediates mycobacterial death. Vet. Immunol. Immunopathol. 2001, 78:249.
63. Teixeira J.M., Oliveira M.C., Parada C.A., Tambeli C.H. Peripheral mechanisms underlying the essential role of P2X7 receptors in the development of inflammatory hyperalgesia. Eur. J. Pharmacol. 2010, 644:55.
64. Vordermeier H.M., Venkataprasad N., Harris D.P., Ivanyi J. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin. Exp. Immunol. 1996, 106:312.
65. Wickelgren I. New clues to how the TB bacillus persists. Science 2000, 288:1314.
66. Wiley J.S., Sluyter R., Gu B.J., Stokes L., Fuller S.J. The human P2X7 receptor and its role in innate immunity. Tissue Antigens 2011, 78:321.
67. World Health Organization Global Tuberculosis Control: WHO Report 2010 2010, WHO, Geneva.
68. World Health Organization Global Tuberculosis Control: WHO Report 2011 2011, WHO, Geneva.